× Meeting the Challenge of Diabetes in China

× Sustainable COVID-19 Mitigation: Wuhan Lockdowns, Health Inequities, and Patient Evacuation

× Patients’ Coping Behaviors to Unavailability of Essential Medicines in Primary Care in Developed Urban China

× Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study

× Medical Service Utilization and Direct Medical Cost of Stroke in Urban China

× Preferential Tax Policies: An Invisible Hand behind Preparedness for Public Health Emergencies

× Competing or Interactive Effect Between Perceived Response Efficacy of Governmental Social Distancing Behaviors and Personal Freedom on Social Distancing Behaviors in the Chinese Adult General Population in Hong Kong

× Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis

× Forecasting Future Demand of Nursing Staff for the Oldest-Old in China by 2025 Based on Markov Model

× Assessment of the Benefits and Cost-Effectiveness of Population-Based Breast Cancer Screening in Urban China: A Model-Based Analysis

× Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province

× Effects of Vertical Integration Reform on Primary Healthcare Institutions in China: Evidence From a Longitudinal Study

× Establishment and Application of an Index System for the Risk of Drug Shortages in China: Based on Delphi Method and Analytic Hierarchy Process

× Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China

× The Feedback Loop Between the Demand for Voluntary Private Insurance and the Burden of Healthcare System: An Explanatory System Dynamics Model of Hong Kong

× Improving Insurance Protection for Rare Diseases: Economic Burden and Policy Effects — Simulation of People With Pompe Disease in China

× The Performance of Primary Healthcare in China: The Need for a Systematic Design for Improvement Comment on “Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China”

× The Impact of Prescribing Monitoring Policy on Drug Use and Expenditures in China: A Multi-center Interrupted Time Series Study

× Rethinking Performance Measurement of Primary Care in China Comment on “Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China”

× Effects of the Long-term Care Insurance on Health Among Older Adults: A Panel Data From China

× Impact of China’s National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin

× Long-term Care Insurance and Health and Perceived Satisfaction of Older Chinese: Comparisons Between Urban/Rural Areas, Chronic Conditions, and Their Intersectionality

× Stakeholders’ Perceived Barriers and Successes of Quality Improvement Programs for Patients With Diabetes Comment on “Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China”

× Subgroups of High-Cost Patients and Their Preventable Inpatient Cost in Rural China